OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ULTR55

ULTRAMARINE & PIGMENTS Ltd

Specialty ChemicalsVerified

The company maintains a strong liquidity position, with a current ratio of 2.93, indicating that it holds nearly three times more current assets than current liabilities. However, the liquidity risk is assessed as medium, primarily due to the negative net cash position after subtracting total debt. The company's cash and equivalents amount to INR 450.39 million, while its long-term debt stands at INR 794.58 million, resulting in a net cash outflow of INR 344.19 million. Profitability metrics show a return on equity (ROE) of 1.21% and a return on assets (ROA) of 1.01%, both of which are below the typical thresholds for high-performing specialty chemical firms. The operating margin, calculated as operating income of INR 139.34 million on revenue of INR 1.36 billion, is approximately 10.28%, which is in line with the industry median for firms in the Specialty Chemicals sector. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The absence of segment-specific revenue breakdowns in the latest financials suggests a need for further transparency in the company's operational structure. Looking ahead, the company is projected to experience a modest growth trajectory, with revenue expected to increase in the current fiscal year. However, the growth rate is not yet quantified in the available data. Historical revenue trends show a stable but non-accelerating pattern, with the most recent reported revenue at INR 1.36 billion. Risk factors include a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio of 0.09 suggests a conservative capital structure, but the negative net cash position raises concerns about short-term liquidity. No significant dilution events are currently flagged, and the number of shares outstanding remains unchanged between basic and diluted shares. Recent events include the filing of the latest financial report, which provides a snapshot of the company's financial health. No major earnings call transcripts or regulatory filings have been disclosed in the available data, limiting the visibility into management's strategic direction and operational performance.

30-day price · ULTR+34.10 (+8.9%)
Low$365.05High$439.00Close$415.25As of12 May, 00:00 UTC
Profile
CompanyULTRAMARINE & PIGMENTS Ltd
TickerULTR.BO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. ULTRAMARINE & PIGMENTS Ltd produces and sells specialty chemicals, primarily focusing on pigments and related products, generating revenue through the sale of these materials to industrial and manufacturing customers.

Classification. The company is classified under the Basic Materials economic sector, within the Chemicals business sector and the Specialty Chemicals industry, with a classification confidence of 0.92.

The company maintains a strong liquidity position, with a current ratio of 2.93, indicating that it holds nearly three times more current assets than current liabilities. However, the liquidity risk is assessed as medium, primarily due to the negative net cash position after subtracting total debt. The company's cash and equivalents amount to INR 450.39 million, while its long-term debt stands at INR 794.58 million, resulting in a net cash outflow of INR 344.19 million. Profitability metrics show a return on equity (ROE) of 1.21% and a return on assets (ROA) of 1.01%, both of which are below the typical thresholds for high-performing specialty chemical firms. The operating margin, calculated as operating income of INR 139.34 million on revenue of INR 1.36 billion, is approximately 10.28%, which is in line with the industry median for firms in the Specialty Chemicals sector. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The absence of segment-specific revenue breakdowns in the latest financials suggests a need for further transparency in the company's operational structure. Looking ahead, the company is projected to experience a modest growth trajectory, with revenue expected to increase in the current fiscal year. However, the growth rate is not yet quantified in the available data. Historical revenue trends show a stable but non-accelerating pattern, with the most recent reported revenue at INR 1.36 billion. Risk factors include a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio of 0.09 suggests a conservative capital structure, but the negative net cash position raises concerns about short-term liquidity. No significant dilution events are currently flagged, and the number of shares outstanding remains unchanged between basic and diluted shares. Recent events include the filing of the latest financial report, which provides a snapshot of the company's financial health. No major earnings call transcripts or regulatory filings have been disclosed in the available data, limiting the visibility into management's strategic direction and operational performance.
Key takeaways
  • The company maintains a strong current ratio but faces a medium liquidity risk due to a negative net cash position.
  • Profitability metrics are below typical thresholds for the Specialty Chemicals industry, with ROE and ROA at 1.21% and 1.01%, respectively.
  • Revenue is concentrated in a single business segment, with no geographic diversification disclosed.
  • The company's capital structure is conservative, with a low debt-to-equity ratio of 0.09 and no immediate dilution risk.
  • Growth projections are modest, with no significant acceleration in revenue trends observed in the latest financial data.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$1.36B
Gross profit$555.7M
Operating income$139.3M
Net income$108.7M
R&D
SG&A
D&A
SBC
Operating cash flow$780.7M
CapEx-$633.0M
Free cash flow
Total assets$10.76B
Total liabilities$1.76B
Total equity$9.00B
Cash & equivalents$450.4M
Long-term debt$794.6M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$3.08B$690.5M$557.9M$218.1M
FY-3$4.90B$717.8M$583.0M-$140.1M
FY-2$5.57B$845.4M$692.0M$110.6M
FY-1$5.61B$722.1M$576.0M$18.1M
FY0$6.95B$945.6M$750.5M$317.7M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$5.61B$4.61B
FY-3$9.95B$8.60B$20.0M
FY-2$8.81B$7.36B$193.6M
FY-1$10.76B$9.00B
FY0$11.73B$9.73B
PeriodOCFCapExFCFSBC
FY-4$577.9M-$428.8M$218.1M
FY-3$290.8M-$696.1M-$140.1M
FY-2$618.2M-$604.4M$110.6M
FY-1$780.7M-$633.0M$18.1M
FY0$899.0M-$528.3M$317.7M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$1.36B$139.3M$108.7M
FQ-6$1.61B$209.4M$165.4M
FQ-5$1.61B$214.8M$186.3M
FQ-4$1.79B$299.5M$228.5M
FQ-3$1.95B$215.5M$170.2M
FQ-2$1.84B$253.9M$201.9M
FQ-1$1.96B$250.5M$193.6M
FQ0$1.96B$318.1M$270.9M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$10.76B$9.00B$450.4M
FQ-6
FQ-5$12.82B$10.83B$487.1M
FQ-4
FQ-3$11.73B$9.73B$603.0M
FQ-2
FQ-1$12.90B$10.63B$649.2M
FQ0
PeriodOCFCapExFCFSBC
FQ-7$780.7M-$633.0M
FQ-6
FQ-5$301.1M-$265.7M
FQ-4
FQ-3$899.0M-$528.3M
FQ-2
FQ-1$577.6M-$365.8M
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$9.00B
Net cash-$344.2M
Current ratio2.9
Debt/Equity0.1
ROA1.0%
ROE1.2%
Cash conversion7.2%
CapEx/Revenue-46.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 4 companies
MetricULTRActivity
Op margin10.3%8.0% medp25 -2.2% · p75 23.4%above median
Net margin8.0%5.5% medp25 -3.8% · p75 18.5%above median
Gross margin41.0%20.5% medp25 12.4% · p75 29.7%top quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-46.7%8.6% medp25 1.7% · p75 15.7%bottom quartile
Debt / equity9.0%37.1% medp25 10.3% · p75 82.0%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-11 00:04 UTC#84dfbde9
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 20:36 UTCJob: 0caed2cd